Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
1.5 34 37 34 37 B-lower_bound
x 38 39 38 39 I-lower_bound
109 40 43 40 43 I-lower_bound
/ 43 44 43 44 I-lower_bound
L 44 45 44 45 I-lower_bound

Alkaline 0 8 46 54 B-clinical_variable
phosphatase 9 20 55 66 I-clinical_variable
≤ 21 22 67 68 O
2.5 23 26 69 72 B-upper_bound
x 27 28 73 74 I-upper_bound
ULN 29 32 75 78 I-upper_bound

Aspartate 0 9 79 88 B-clinical_variable
aminotransferase 10 26 89 105 I-clinical_variable
( 27 28 106 107 I-clinical_variable
AST 28 31 107 110 I-clinical_variable
) 31 32 110 111 I-clinical_variable
( 33 34 112 113 O
SGOT 34 38 113 117 B-clinical_variable
) 38 39 117 118 O
and 40 43 119 122 O
Alanine 44 51 123 130 B-clinical_variable
aminostransferase 52 69 131 148 I-clinical_variable
( 70 71 149 150 I-clinical_variable
ALT 71 74 150 153 I-clinical_variable
) 74 75 153 154 I-clinical_variable
( 76 77 155 156 O
SGPT 77 81 156 160 B-clinical_variable
) 81 82 160 161 O
< 83 84 162 163 O
3 85 86 164 165 B-upper_bound
x 87 88 166 167 I-upper_bound
ULN 89 92 168 171 I-upper_bound

Basophilia 0 10 172 182 B-clinical_variable
≥ 11 12 183 184 O
20 13 15 185 187 B-lower_bound
% 15 16 187 188 I-lower_bound
in 17 19 189 191 O
blood 20 25 192 197 O
or 26 28 198 200 O
BM 29 31 201 203 O

Blasts 0 6 204 210 B-clinical_variable
plus 7 11 211 215 I-clinical_variable
progranulocytes 12 27 216 231 I-clinical_variable
≥ 28 29 232 233 O
30 30 32 234 236 B-lower_bound
% 32 33 236 237 I-lower_bound
in 34 36 238 240 O
blood 37 42 241 246 O
or 43 45 247 249 O
bone 46 50 250 254 O
marrow 51 57 255 261 O
( 58 59 262 263 O
BM 59 61 263 265 O
) 61 62 265 266 O

Blasts 0 6 267 273 B-clinical_variable
≥ 7 8 274 275 O
15 9 11 276 278 B-lower_bound
% 11 12 278 279 I-lower_bound
in 13 15 280 282 O
blood 16 21 283 288 O
or 22 24 289 291 O
BM 25 27 292 294 O

Chronic 0 7 295 302 B-cancer
phase 8 13 303 308 I-cancer
: 13 14 308 309 O
None 15 19 310 314 O
of 20 22 315 317 O
the 23 26 318 321 O
criteria 27 35 322 330 O
for 36 39 331 334 O
accelerated 40 51 335 346 O
or 52 54 347 349 O
blastic 55 62 350 357 B-cancer
phase 63 68 358 363 I-cancer

Clinically 0 10 364 374 O
significant 11 22 375 386 O
resting 23 30 387 394 O
brachycardia 31 43 395 407 B-chronic_disease
( 44 45 408 409 O
< 45 46 409 410 O
50 46 48 410 412 B-upper_bound
beats 49 54 413 418 I-upper_bound
per 55 58 419 422 I-upper_bound
minute 59 65 423 429 I-upper_bound
) 65 66 429 430 O

Complete 0 8 431 439 B-chronic_disease
left 9 13 440 444 I-chronic_disease
bundle 14 20 445 451 I-chronic_disease
branch 21 27 452 458 I-chronic_disease
block 28 33 459 464 I-chronic_disease

Congenital 0 10 465 475 O
long 11 15 476 480 B-chronic_disease
QT 16 18 481 483 I-chronic_disease
syndrome 19 27 484 492 I-chronic_disease
or 28 30 493 495 O
a 31 32 496 497 O
known 33 38 498 503 O
family 39 45 504 510 O
history 46 53 511 518 O
of 54 56 519 521 O
long 57 61 522 526 O
QT 62 64 527 529 O
syndrome 65 73 530 538 O

Creatinine 0 10 539 549 B-clinical_variable
< 11 12 550 551 O
1.5 13 16 552 555 B-upper_bound
x 17 18 556 557 I-upper_bound
upper 19 24 558 563 I-upper_bound
limit 25 30 564 569 I-upper_bound
of 31 33 570 572 I-upper_bound
normal 34 40 573 579 I-upper_bound
( 41 42 580 581 I-upper_bound
ULN 42 45 581 584 I-upper_bound
) 45 46 584 585 I-upper_bound

Cytogenetic 0 11 586 597 B-chronic_disease
clonal 12 18 598 604 I-chronic_disease
evolution 19 28 605 614 I-chronic_disease

Documented 0 10 615 625 O
diagnosis 11 20 626 635 O
of 21 23 636 638 O
Ph+ 24 27 639 642 O
Chronic 28 35 643 650 O
phase 36 41 651 656 O
CML 42 45 657 660 B-cancer

Eastern 0 7 661 668 B-clinical_variable
Cooperative 8 19 669 680 I-clinical_variable
Oncology 20 28 681 689 I-clinical_variable
Group 29 34 690 695 I-clinical_variable
( 35 36 696 697 I-clinical_variable
ECOG 36 40 697 701 I-clinical_variable
) 40 41 701 702 I-clinical_variable
Performance 42 53 703 714 I-clinical_variable
status 54 60 715 721 I-clinical_variable
0,1 61 64 722 725 B-lower_bound
, 64 65 725 726 O
or 66 68 727 729 O
2 69 70 730 731 B-upper_bound

Extramedullary 0 14 732 746 B-cancer
disease 15 22 747 754 I-cancer
with 23 27 755 759 O
localized 28 37 760 769 O
immature 38 46 770 778 O
blasts 47 53 779 785 O

History 0 7 786 793 O
of 8 10 794 796 O
acute 11 16 797 802 B-chronic_disease
pancreatitis 17 29 803 815 I-chronic_disease
within 30 36 816 822 O
1 37 38 823 824 B-upper_bound
year 39 43 825 829 I-upper_bound
of 44 46 830 832 O
study 47 52 833 838 O
entry 53 58 839 844 O
or 59 61 845 847 O
past 62 66 848 852 O
medical 67 74 853 860 O
history 75 82 861 868 O
of 83 85 869 871 O
chronic 86 93 872 879 B-chronic_disease
pancreatitis 94 106 880 892 I-chronic_disease

History 0 7 893 900 O
of 8 10 901 903 O
another 11 18 904 911 O
active 19 25 912 918 O
malignancy 26 36 919 929 B-cancer
within 37 43 930 936 O
5 44 45 937 938 B-upper_bound
years 46 51 939 944 I-upper_bound
prior 52 57 945 950 I-upper_bound
to 58 60 951 953 O
study 61 66 954 959 O
entry 67 72 960 965 O

History 0 7 966 973 O
of 8 10 974 976 O
or 11 13 977 979 O
presence 14 22 980 988 O
of 23 25 989 991 O
clinically 26 36 992 1002 O
significant 37 48 1003 1014 O
ventricular 49 60 1015 1026 B-chronic_disease
or 61 63 1027 1029 O
atrial 64 70 1030 1036 B-chronic_disease
tachyarrhythmias 71 87 1037 1053 I-chronic_disease

History 0 7 1054 1061 O
of 8 10 1062 1064 O
unstable 11 19 1065 1073 B-chronic_disease
angina 20 26 1074 1080 I-chronic_disease
within 27 33 1081 1087 O
1 34 35 1088 1089 B-upper_bound
year 36 40 1090 1094 I-upper_bound
of 41 43 1095 1097 O
study 44 49 1098 1103 O
entry 50 55 1104 1109 O

Impaired 0 8 1110 1118 B-chronic_disease
cardiac 9 16 1119 1126 I-chronic_disease
function 17 25 1127 1135 I-chronic_disease

Impaired 0 8 1136 1144 B-chronic_disease
gastrointestinal 9 25 1145 1161 I-chronic_disease
( 26 27 1162 1163 I-chronic_disease
GI 27 29 1163 1165 I-chronic_disease
) 29 30 1165 1166 I-chronic_disease
function 31 39 1167 1175 I-chronic_disease
or 40 42 1176 1178 O
GI 43 45 1179 1181 B-chronic_disease
disease 46 53 1182 1189 I-chronic_disease
that 54 58 1190 1194 O
may 59 62 1195 1198 O
significantly 63 76 1199 1212 O
alter 77 82 1213 1218 O
the 83 86 1219 1222 O
absorption 87 97 1223 1233 O
of 98 100 1234 1236 O
study 101 106 1237 1242 B-treatment
drug 107 111 1243 1247 I-treatment
( 112 113 1248 1249 O
e.g. 113 117 1249 1253 O
, 117 118 1253 1254 O
ulcerative 119 129 1255 1265 B-chronic_disease
diseases 130 138 1266 1274 I-chronic_disease
, 138 139 1274 1275 O
uncontrolled 140 152 1276 1288 O
nausea 153 159 1289 1295 O
, 159 160 1295 1296 O
vomiting 161 169 1297 1305 O
, 169 170 1305 1306 O
diarrhea 171 179 1307 1315 B-chronic_disease
, 179 180 1315 1316 O
malabsorption 181 194 1317 1330 B-chronic_disease
syndrome 195 203 1331 1339 I-chronic_disease
, 203 204 1339 1340 O
small 205 210 1341 1346 B-chronic_disease
bowel 211 216 1347 1352 I-chronic_disease
resection 217 226 1353 1362 I-chronic_disease
or 227 229 1363 1365 O
gastric 230 237 1366 1373 B-treatment
bypass 238 244 1374 1380 I-treatment
surgery 245 252 1381 1388 I-treatment
) 252 253 1388 1389 O

Inability 0 9 1390 1399 O
to 10 12 1400 1402 O
monitor 13 20 1403 1410 O
the 21 24 1411 1414 O
QT 25 27 1415 1417 O
interval 28 36 1418 1426 O
on 37 39 1427 1429 O
ECG 40 43 1430 1433 B-treatment

Known 0 5 1434 1439 O
presence 6 14 1440 1448 O
of 15 17 1449 1451 O
significant 18 29 1452 1463 O
congenital 30 40 1464 1474 O
or 41 43 1475 1477 O
acquired 44 52 1478 1486 O
bleeding 53 61 1487 1495 B-chronic_disease
disorder 62 70 1496 1504 I-chronic_disease
unrelated 71 80 1505 1514 O
to 81 83 1515 1517 O
cancer 84 90 1518 1524 B-cancer

Major 0 5 1525 1530 O
surgery 6 13 1531 1538 B-treatment
within 14 20 1539 1545 O
4 21 22 1546 1547 B-upper_bound
weeks 23 28 1548 1553 I-upper_bound
prior 29 34 1554 1559 I-upper_bound
to 35 37 1560 1562 O
Day 38 41 1563 1566 O
1 42 43 1567 1568 O
of 44 46 1569 1571 O
the 47 50 1572 1575 O
study 51 56 1576 1581 O
or 57 59 1582 1584 O
who 60 63 1585 1588 O
have 64 68 1589 1593 O
not 69 72 1594 1597 O
recovered 73 82 1598 1607 O
from 83 87 1608 1612 O
prior 88 93 1613 1618 B-treatment
surgery 94 101 1619 1626 I-treatment

Myocardial 0 10 1627 1637 B-chronic_disease
infarction 11 21 1638 1648 I-chronic_disease
within 22 28 1649 1655 O
12 29 31 1656 1658 B-upper_bound
months 32 38 1659 1665 I-upper_bound
prior 39 44 1666 1671 I-upper_bound
to 45 47 1672 1674 O
starting 48 56 1675 1683 O
study 57 62 1684 1689 O
Other 63 68 1690 1695 O
clinically 69 79 1696 1706 O
significant 80 91 1707 1718 O
uncontrolled 92 104 1719 1731 O
heart 105 110 1732 1737 B-chronic_disease
disease 111 118 1738 1745 I-chronic_disease

Patients 0 8 1746 1754 O
18 9 11 1755 1757 B-lower_bound
years 12 17 1758 1763 I-lower_bound
or 18 20 1764 1766 O
older 21 26 1767 1772 O

Patients 0 8 1773 1781 O
currently 9 18 1782 1791 O
receiving 19 28 1792 1801 O
treatment 29 38 1802 1811 B-treatment
with 39 43 1812 1816 O
any 44 47 1817 1820 O
medications 48 59 1821 1832 O
that 60 64 1833 1837 O
have 65 69 1838 1842 O
the 70 73 1843 1846 O
potential 74 83 1847 1856 O
to 84 86 1857 1859 O
prolong 87 94 1860 1867 O
the 95 98 1868 1871 O
QT 99 101 1872 1874 O
interval 102 110 1875 1883 O
and 111 114 1884 1887 O
the 115 118 1888 1891 O
treatment 119 128 1892 1901 O
can 129 132 1902 1905 O
not 132 135 1905 1908 O
be 136 138 1909 1911 O
either 139 145 1912 1918 O
discontinued 146 158 1919 1931 O
or 159 161 1932 1934 O
switched 162 170 1935 1943 O
to 171 173 1944 1946 O
a 174 175 1947 1948 O
different 176 185 1949 1958 O
medication 186 196 1959 1969 O
prior 197 202 1970 1975 O
to 203 205 1976 1978 O
starting 206 214 1979 1987 O
study 215 220 1988 1993 B-treatment
drug 221 225 1994 1998 I-treatment
( 226 227 1999 2000 O
http://crediblemeds.org/ 227 251 2000 2024 O
) 251 252 2024 2025 O

Patients 0 8 2026 2034 O
currently 9 18 2035 2044 B-treatment
receiving 19 28 2045 2054 I-treatment
treatment 29 38 2055 2064 I-treatment
with 39 43 2065 2069 I-treatment
strong 44 50 2070 2076 I-treatment
CYP3A4 51 57 2077 2083 I-treatment
inhibitors 58 68 2084 2094 I-treatment
and 69 72 2095 2098 O
treatment 73 82 2099 2108 O
can 83 86 2109 2112 O
not 86 89 2112 2115 O
be 90 92 2116 2118 O
either 93 99 2119 2125 O
discontinued 100 112 2126 2138 O
or 113 115 2139 2141 O
switched 116 124 2142 2150 O
to 125 127 2151 2153 O
a 128 129 2154 2155 O
different 130 139 2156 2165 O
medication 140 150 2166 2176 B-treatment
prior 151 156 2177 2182 O
to 157 159 2183 2185 O
starting 160 168 2186 2194 O
study 169 174 2195 2200 O
drug 175 179 2201 2205 O
. 179 180 2205 2206 O
( 181 182 2207 2208 O
http://medicine.iupui.edu/clinpharm/ddis/ 182 223 2208 2249 O
) 223 224 2249 2250 O
) 225 226 2251 2252 O

Platelets 0 9 2253 2262 B-clinical_variable
< 10 11 2263 2264 O
100 12 15 2265 2268 B-upper_bound
× 16 17 2269 2270 I-upper_bound
109 18 21 2271 2274 I-upper_bound
/ 21 22 2274 2275 I-upper_bound
L 22 23 2275 2276 I-upper_bound
unrelated 24 33 2277 2286 O
to 34 36 2287 2289 O
therapy 37 44 2290 2297 B-treatment

Platelets 0 9 2298 2307 B-clinical_variable
> 10 11 2308 2309 O
100 12 15 2310 2313 B-lower_bound
x 16 17 2314 2315 I-lower_bound
109 18 21 2316 2319 I-lower_bound
/ 21 22 2319 2320 I-lower_bound
L 22 23 2320 2321 I-lower_bound

Pregnant 0 8 2322 2330 B-pregnancy

Previous 0 8 2331 2339 B-treatment
treatment 9 18 2340 2349 I-treatment
with 19 23 2350 2354 O
any 24 27 2355 2358 O
other 28 33 2359 2364 O
tyrosine 34 42 2365 2373 B-treatment
kinase 43 49 2374 2380 I-treatment
inhibitor 50 59 2381 2390 I-treatment
except 60 66 2391 2397 O
for 67 70 2398 2401 O
up 71 73 2402 2404 O
to 74 76 2405 2407 O
2 77 78 2408 2409 B-upper_bound
weeks 79 84 2410 2415 I-upper_bound
of 85 87 2416 2418 O
nilotinib 88 97 2419 2428 B-treatment

Q 0 1 2429 2430 B-clinical_variable
- 1 2 2430 2431 I-clinical_variable
T 2 3 2431 2432 I-clinical_variable
Corrected 4 13 2433 2442 I-clinical_variable
( 14 15 2443 2444 I-clinical_variable
corrected 15 24 2444 2453 I-clinical_variable
Q 25 26 2454 2455 I-clinical_variable
- 26 27 2455 2456 I-clinical_variable
T 27 28 2456 2457 I-clinical_variable
interval 29 37 2458 2466 I-clinical_variable
) 37 38 2466 2467 I-clinical_variable
( 39 40 2468 2469 I-clinical_variable
QTc 40 43 2469 2472 I-clinical_variable
) 43 44 2472 2473 I-clinical_variable
> 45 46 2474 2475 O
450 47 50 2476 2479 B-lower_bound
msec 51 55 2480 2484 I-lower_bound
on 56 58 2485 2487 O
baseline 59 67 2488 2496 O
ECG 68 71 2497 2500 O

Right 0 5 2501 2506 B-chronic_disease
bundle 6 12 2507 2513 I-chronic_disease
branch 13 19 2514 2520 I-chronic_disease
block 20 25 2521 2526 I-chronic_disease
plus 26 30 2527 2531 O
left 31 35 2532 2536 B-chronic_disease
anterior 36 44 2537 2545 I-chronic_disease
/ 44 45 2545 2546 O
posterior 45 54 2546 2555 B-chronic_disease
hemiblock 55 64 2556 2565 I-chronic_disease

Serum 0 5 2566 2571 B-clinical_variable
amylase 6 13 2572 2579 I-clinical_variable
and 14 17 2580 2583 I-clinical_variable
lipase 18 24 2584 2590 I-clinical_variable
≤ 25 26 2591 2592 O
2 27 28 2593 2594 B-upper_bound
x 29 30 2595 2596 I-upper_bound
ULN 31 34 2597 2600 I-upper_bound

Total 0 5 2601 2606 B-clinical_variable
bilirubin 6 15 2607 2616 I-clinical_variable
< 16 17 2617 2618 O
1.5 18 21 2619 2622 B-upper_bound
x 22 23 2623 2624 I-upper_bound
ULN 24 27 2625 2628 I-upper_bound
( 28 29 2629 2630 O
Does 29 33 2630 2634 O
not 34 37 2635 2638 O
apply 38 43 2639 2644 O
to 44 46 2645 2647 O
patients 47 55 2648 2656 O
with 56 60 2657 2661 O
isolated 61 69 2662 2670 O
hyperbilirubinemia 70 88 2671 2689 B-chronic_disease
[ 89 90 2690 2691 O
e.g. 90 94 2691 2695 O
, 94 95 2695 2696 O
Gilbert 96 103 2697 2704 B-chronic_disease
's 103 105 2704 2706 I-chronic_disease
disease 106 113 2707 2714 I-chronic_disease
] 113 114 2714 2715 O
grade 115 120 2716 2721 O
<3 121 123 2722 2724 O
) 123 124 2724 2725 O

Treatment 0 9 2726 2735 B-treatment
with 10 14 2736 2740 I-treatment
other 15 20 2741 2746 I-treatment
investigational 21 36 2747 2762 I-treatment
agents 37 43 2763 2769 I-treatment
within 44 50 2770 2776 O
30 51 53 2777 2779 B-upper_bound
days 54 58 2780 2784 I-upper_bound
of 59 61 2785 2787 O
Day 62 65 2788 2791 O
1 66 67 2792 2793 O

Use 0 3 2794 2797 O
of 4 6 2798 2800 O
ventricular 7 18 2801 2812 B-treatment
- 18 19 2812 2813 I-treatment
paced 19 24 2813 2818 I-treatment
pacemaker 25 34 2819 2828 I-treatment

congestive 0 10 2829 2839 B-chronic_disease
heart 11 16 2840 2845 I-chronic_disease
failure 17 24 2846 2853 I-chronic_disease

nursing 0 7 2854 2861 O
( 8 9 2862 2863 O
lactating 9 18 2863 2872 O
) 18 19 2872 2873 O
women 20 25 2874 2879 B-gender

previous 0 8 2880 2888 O
or 9 11 2889 2891 O
concomitant 12 23 2892 2903 O
basal 24 29 2904 2909 B-cancer
cell 30 34 2910 2914 I-cancer
skin 35 39 2915 2919 I-cancer
cancer 40 46 2920 2926 I-cancer
and 47 50 2927 2930 O
previous 51 59 2931 2939 O
carcinoma 60 69 2940 2949 B-cancer
in 70 72 2950 2952 I-cancer
situ 73 77 2953 2957 I-cancer
treated 78 85 2958 2965 O
curatively 86 96 2966 2976 O

uncontrolled 0 12 2977 2989 B-chronic_disease
diabetes 13 21 2990 2998 I-chronic_disease

uncontrolled 0 12 2999 3011 O
hypertension 13 25 3012 3024 B-chronic_disease

uncontrolled 0 12 3025 3037 B-chronic_disease
infection 13 22 3038 3047 I-chronic_disease

unstable 0 8 3048 3056 B-chronic_disease
angina 9 15 3057 3063 I-chronic_disease

≥ 0 1 3064 3065 O
30 2 4 3066 3068 B-lower_bound
% 4 5 3068 3069 I-lower_bound
blasts 6 12 3070 3076 I-lower_bound
in 13 15 3077 3079 O
blood 16 21 3080 3085 O
or 22 24 3086 3088 O
BM 25 27 3089 3091 O

